Macy’s Outlines Store Opening Plans, Plus Spring Apparel Strategy
Large industry customer Macy’s detailed how much volume it expects reopened stores to do, how it plans to…
Executive Edition April 30, 2020
Latest In: Financial News
Hydro Flask’s Full Year Results Plus Current Sales Trends
Parent company Helen of Troy detailed how much Hydro Flask's sales grew last year, plus what they are…
News April 29, 2020
Adidas Details Coronavirus Impacts in Q1, Shares Grim Outlook for Q2
Adidas reported weak results for Q1 and said Q2 is expected to be worse on the top and…
News April 27, 2020
Rip Curl Shines for New Owner Kathmandu
How Rip Curl performed on the top and bottom lines over the holiday season, plus how Kathmandu wants…
Executive Edition April 2, 2020
Oakley and Costa Owner Comments on 2019 Results
EssilorLuxottica provided some details about how the brands' financial year turned out.
Executive Edition March 6, 2020
Columbia Expects “Significant Impact” from Coronavirus
The supply chain impacts will likely affect Columbia's ability to timely fulfill orders and meet consumer demand. In…
News February 27, 2020
Rip Curl Performance Detailed by New Owner Kathmandu
The company released information about how Rip Curl has performed during the first three months of Kathmandu ownership.
Executive Edition February 10, 2020
Columbia Executives on Outerwear Softness, Coronavirus Supply Chain Worries
Columbia Sportswear posted strong results for 2019, but executives noted areas of concern during an earnings conference call…
Executive Edition February 7, 2020
How Levi’s Plans to Rebuild the U.S. Business
Impacted by large retailers closing stores, Levi's executives outline plans for the U.S. market, which include some controversial…
Executive Edition February 6, 2020
Macy’s to Shutter Stores and Slash Jobs in Major Restructuring
Important industry customer Macy’s announced a major restructuring Tuesday afternoon.
Executive Edition February 4, 2020
Deckers Brands Posts Strong Q3 Despite Sanuk Softness
Several brands outperform in Q3, however, challenges remain at Teva and Sanuk.
Executive Edition February 4, 2020
Executive Edition
